Literature DB >> 15854249

Surgical management of 33 ilioinguinal and iliohypogastric neuralgias at Louisiana State University Health Sciences Center.

Daniel H Kim1, Judith A Murovic, Robert L Tiel, David G Kline.   

Abstract

OBJECTIVE: This is a retrospective review of 33 charts of patients with ilioinguinal and iliohypogastric neuralgias who underwent a neurectomy at Louisiana State University Health Sciences Center between 1967 and 2000. Operations associated with neuralgias and postoperative pain outcomes were analyzed.
METHODS: There were 23 ilioinguinal and 10 combined ilioinguinal-iliohypogastric neuralgias, and the side of the lesion and sex of the patient were found to be evenly distributed in this group. Nerve blocks must have resulted in a complete or substantial decrease in pain before a neurectomy was recommended. Twenty-nine (88%) of 33 neuralgia patients had injuries from iatrogenic causes, and 4 (12%) injuries were caused by blunt trauma. In the 23 isolated ilioinguinal neuralgias, the operation associated with neuralgias in 13 (57%) of 23 patients was a herniorrhaphy. This was followed by 4 (17%) neuralgias after an appendectomy and 3 (13%) after a hysterectomy. Three (13%) patients had neuralgias resulting from blunt trauma. Nine (90%) of 10 ilioinguinal-iliohypogastric lesions were caused by iatrogenic causes, and 1 (10%) neuralgia resulted from blunt trauma. A neurectomy was performed in all patients.
RESULTS: The neurectomy resulted in considerable pain relief in 21 (91%) of 23 patients with ilioinguinal lesions and 9 (90%) of 10 patients with ilioinguinal-iliohypogastric lesions. Postoperative side effects were persistent numbness below the resected nerve and loss of the cremasteric reflex. Minor postoperative complications consisted of two superficial skin infections.
CONCLUSION: Ilioinguinal and ilioinguinal-iliohypogastric neuralgias are infrequent conditions; however, 33 patients from the Louisiana State University Health Sciences Center were accrued and analyzed in this study, and most had significant pain relief after neurectomy.

Entities:  

Mesh:

Year:  2005        PMID: 15854249

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Pulsed radiofrequency for the treatment of chronic ilioinguinal neuropathy.

Authors:  Raj Mitra; Afshin Zeighami; Sean Mackey
Journal:  Hernia       Date:  2007-02-02       Impact factor: 4.739

2.  Current trends in the diagnosis and management of post-herniorraphy chronic groin pain.

Authors:  Abdul Hakeem; Venkatesh Shanmugam
Journal:  World J Gastrointest Surg       Date:  2011-06-27

Review 3.  Management of persistent postsurgical inguinal pain.

Authors:  Mads U Werner
Journal:  Langenbecks Arch Surg       Date:  2014-05-23       Impact factor: 3.445

4.  International guidelines for groin hernia management.

Authors: 
Journal:  Hernia       Date:  2018-01-12       Impact factor: 4.739

5.  Factors Determining Outcome After Surgery for Chronic Groin Pain Following a Lichtenstein Hernia Repair.

Authors:  Willem A R Zwaans; Tim Verhagen; Rudi M H Roumen; Marc R M Scheltinga
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

6.  Surgical management of postoperative chronic inguinodynia by laparoscopic transabdominal preperitoneal approach.

Authors:  A Moreno-Egea
Journal:  Surg Endosc       Date:  2016-03-22       Impact factor: 4.584

Review 7.  Sonoanatomy of the ilioinguinal, iliohypogastric, genitofemoral, obturator, and pudendal nerves: a practical guide for US-guided injections.

Authors:  Elena E Drakonaki; Miraude E A P M Adriaensen; Hussain I J Al-Bulushi; Ioannis Koliarakis; John Tsiaoussis; Kurt Vanderdood
Journal:  J Ultrason       Date:  2022-02-08

8.  Transabdominal laparoscopic retroperitoneal neurectomy for chronic pain after inguinal hernia repair and appendicectomy -a matched-pair study.

Authors:  Ioannis Karampinis; Johannes Weiss; Lothar Pilz; Stefan Post; Florian Herrle
Journal:  BMC Surg       Date:  2017-07-20       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.